Sector pending / General Medical and Surgical HospitalsUpdated 2026-05-10 22:07 UTC

FRA/GHC stock hub

FRA/GHC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/GHCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

464.6M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/GHCFRA/GHC

—

Loading chart…

In the news

Latest news · FRA/GHC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/E19.8

P25 n/aP50 n/aP75 n/a

ROE6.9

P25 n/aP50 n/aP75 n/a

ROIC6.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/GHC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

EUR

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	DE
Employees	2,526
Employees Change	157%
Employees Change Percent	5.8
Enterprise value	EUR 681M
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	General Medical and Surgical Hospitals
Last refreshed	2026-05-10
Market cap	EUR 464.6M
Price	EUR 5.08
Price currency	EUR
Rev Per Employee	192,356.46x
Sic	8062
Symbol	fra/GHC
Website	https://www.garofalohealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.04%
EV Earnings	29.09x
EV/EBIT	13.36x
EV/EBITDA	8.81x
EV/FCF	37.58x
EV/Sales	1.4x
FCF yield	3.9%
Forward P/E	18.73x
P/B ratio	1.33x
P/E ratio	19.85x
P/S ratio	0.96x
PE Ratio10 Y	25.8x
PE Ratio3 Y	18.85x
PE Ratio5 Y	20.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.49%
EBITDA Margin	15.29%
FCF margin	3.74%
Gross margin	21.42%
Gross Profit	EUR 103.9M
Gross Profit Growth	4.07%
Gross Profit Growth Q	-1.36%
Gross Profit Growth3 Y	14.81%
Gross Profit Growth5 Y	21.5%
Net Income	EUR 23.4M
Net Income Growth	7.87%
Net Income Growth Q	-94.52%
Net Income Growth3 Y	2.99%
Net Income Growth5 Y	14.72%
Pretax Margin	7%
Profit Margin	4.83%
Profit Per Employee	EUR 9,282
ROA	3.72
Roa5y	3.71
ROCE	7.04
ROE	6.9
Roe5y	7.41
ROIC	6.37
Roic5y	6.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.12%
Cagr3y	10.87%
Cagr5y	0.42%
EPS Growth	8.33
EPS Growth Q	-97.02
EPS Growth3 Y	2.7
EPS Growth5 Y	13.18
FCF Growth	8.51%
FCF Growth3 Y	-15.5%
FCF Growth5 Y	8.65%
OCF Growth	40.15%
OCF Growth Q	198.27%
OCF Growth3 Y	3.79%
OCF Growth5 Y	16.39%
Revenue Growth	3.71x
Revenue Growth Q	1.26x
Revenue Growth3 Y	14.87x
Revenue Growth5 Y	18.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.57
Assets	EUR 859.8M
Cash	EUR 19.9M
Current Assets	EUR 167.6M
Current Liabilities	EUR 136.6M
Debt	EUR 225.4M
Debt EBITDA	EUR 2.92
Debt Equity	EUR 0.64
Debt FCF	EUR 12.44
Equity	EUR 349.8M
Interest Coverage	4.7
Liabilities	EUR 510M
Long Term Assets	EUR 692.3M
Long Term Liabilities	EUR 373.4M
Net Cash	EUR -205.5M
Net Cash By Market Cap	EUR -44.24
Net Debt EBITDA	EUR 2.77
Net Debt Equity	EUR 0.59
Net Debt FCF	EUR 11.34
Tangible Book Value	EUR -34.5M
Tangible Book Value Per Share	EUR -0.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.23
Inventory Turnover	62.02
Net Working Capital	EUR 16.9M
Quick ratio	1.07
Working Capital	EUR 31M
Working Capital Turnover	EUR 19.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.77%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	EUR 0.09
Dividend Years	2
Dividend Yield	1.83%
Ex Div Date	2026-05-18
Last Dividend	EUR 0.09
Payout Frequency	Annual
Payout Ratio	32.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.12%
200-day SMA	5.06
3Y total return	36.3%
50-day SMA	4.86
50-day SMA vs 200-day SMA	50under200
5Y total return	2.09%
All Time High	6.02
All Time High Change	-15.61%
All Time High Date	2021-11-19
All Time Low	3.45
All Time Low Change	47.29%
All Time Low Date	2018-11-16
ATR	0.25
Ch YTD	-6.96
High	5.08
High52	5.71
High52 Date	2025-12-03
High52ch	-11.03%
Low	4.91
Low52	4.16
Low52 Date	2026-03-31
Low52ch	22.26%
Ma50ch	4.44%
Price vs 200-day SMA	0.4%
RSI	63.11
RSI Monthly	51.09
RSI Weekly	50.7
Sharpe ratio	-0.04x
Sortino ratio	0.19
Total Return	2.6%
Tr YTD	-6.96
Tr1m	9.01%
Tr1w	2.01%
Tr3m	-5.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 50.9M
Operating Income Growth	0.5
Operating Income Growth Q	-19.45
Operating Income Growth3 Y	12.52
Operating Income Growth5 Y	24.56
Operating margin	10.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,043,328%
Net Borrowing	-12,864,000
Shares Insiders	12.72%
Shares Institutions	3.72%
Shares Yo Y	-0.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 18.1M
Average Volume	0x
Bv Per Share	3.84
CAPEX	EUR -30.9M
Ch1m	9.01
Ch1w	2.01
Ch1y	-1.55
Ch3m	-5.22
Ch3y	34.04
Ch5y	0.4
Ch6m	0.59
Change	0%
Change From Open	3.46
Close	5.08
Days Gap	-3.35
Depreciation Amortization	23,291,000
Earnings Date	2026-05-14
EBIT	EUR 50.9M
EBITDA	EUR 74.2M
EPS	EUR 0.26
F Score	7
FCF	EUR 18.1M
FCF EV Yield	2.66x
Financing CF	-21,849,000
Fiscal Year End	December
Founded	2,000
Goodwill	91,542,000
Graham Number	4.69285
Graham Upside	-7.62
Income Tax	EUR 10.4M
Investing CF	-33,973,000
Is Primary Listing	0
Last Earnings Date	2025-11-21
Last Report Date	2025-12-31
Lynch Fair Value	EUR 3.77
Lynch Upside	-25.84
Ma150	5.13
Ma150ch	-1.05%
Ma20	4.85
Ma20ch	4.81%
Net CF	-6,778,000
Next Earnings Date	2026-05-14
Open	4.91
P FCF Ratio	25.64
P OCF Ratio	9.47
Payment Date	2026-05-20
Position In Range	100
Ppne	301,371,000
Price Date	2026-05-08
Price EBITDA	EUR 6.26
Relative Volume	2,000x
Revenue	485,123,000x
Tax By Revenue	2.14x
Tax Rate	30.61%
Tr6m	0.59%
Volume	0
Z Score	1.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/GHC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.09 annual per share

Payout ratio

+32.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+2.6%

Next ex-dividend date: 2026-05-18

Performance

FRA/GHC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/GHC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.7%

Share of float held by funds and institutions

Insider ownership

+12.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

FRA/GHC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.1

Neutral momentum band

Price vs 200-day MA

+0.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/GHC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/GHC stock rating?

fra/GHC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/GHC analysis?

The full report lives at /stocks/fra/GHC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/GHC?

The latest report frames fra/GHC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/GHC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.